Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display - Cocktail

1064 - Targeted sequencing of germline colorectal cancer predisposition genes in young Asians


24 Nov 2018


Poster display - Cocktail


Genetic Testing and Counselling;  Targeted Therapy;  Genetic and Genomic Testing;  Cancer in Adolescents and Young Adults (AYA)

Tumour Site

Colon and Rectal Cancer


Jianbang Chiang


Annals of Oncology (2018) 29 (suppl_9): ix28-ix45. 10.1093/annonc/mdy431


J. Chiang1, M.R. Toh2, J. Ngeow1

Author affiliations

  • 1 Medical Onocology, National Cancer Centre Singapore, 169610 - Singapore/SG
  • 2 Duke-nus Medical School, Singapore General Hospital/Singhealth, 169856 - Singapore/SG


Abstract 1064


The incidence of colorectal cancer in young patients is rising. Genetic predisposition is postulated to be responsible for up to 30% of all colorectal cancer. However, only 10% are detected currently. We postulate that the current approach with a detailed family history may be insufficient. More detailed genetic screening has to done for this group of patients.


We collected clinical data and blood samples from patients referred to a tertiary cancer centre from November 2014 to December 2016. All patients were less than 50 years old. Targeted genome sequencing was used to identify germline mutations in an array of cancer associated genes. These genes were screened for pathogenicity using the classification guidelines of the American College of Medical Genetics and Genomics.


91 young patients were diagnosed with colorectal cancer. 5 patients (5.5%) had Lynch syndrome by Amsterdam II criteria. 2 patients (2.2%) had tumours with microsatellite instability. Using targeted genomic sequencing, we identified 9 patients (9.9%) with pathogenic or likely pathogenic variants. These were 4 mutations in APC, 1 mutation in ATM, 2 mutations in MUTYH and 2 mutations in RET. No pathogenic germline mutations were found in the mismatch repair genes MLH1, MSH2, MSH6, PMS2, EPCAM.


1 in 10 young patients with colorectal cancer was found to have germline pathogenic variants. Notably, none of the patients in this Asian cohort has a germline mutation in the mismatch repair genes. With a detailed history, we only managed to identify 1 in 20 patients. It is important to screen for germline mutations in young patients with colorectal cancer as these patients have a high risk for development of metachronous colorectal cancer. They will benefit from close surveillance and genetic counselling.

Editorial acknowledgement

Clinical trial identification

Legal entity responsible for the study

National Cancer Centre Singapore.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.